Funding Rounds
Lunaphore

Lunaphore Series D (2023, $32M)

Lunaphore

Tissue autostainers utilizing microfluidics to perform assays on cancer patient tissue samples.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series D

Raised Amount: $32.77M